American Portfolios Advisors Marker Therapeutics, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Marker Therapeutics, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 21,170 shares of MRKR stock, worth $26,462. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,170Holding current value
$26,462% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding MRKR
# of Institutions
5Shares Held
475KCall Options Held
0Put Options Held
0About Marker Therapeutics, Inc.
- Ticker MRKR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,599,200
- Market Cap $104M
- Description
- Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...